找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: International Symposium on Adriamycin; Milan, 9th-10th Sept Stephen K. Carter,A. Di Marco,G. Mathé Conference proceedings 1972 Springer-Ver

[復(fù)制鏈接]
樓主: 詞源法
31#
發(fā)表于 2025-3-26 23:19:20 | 只看該作者
32#
發(fā)表于 2025-3-27 04:35:41 | 只看該作者
Antitumor Effects of Adriamycin on Yoshida Rat Sarcoma and L 1210 Mouse Leukemia — Cross-resistance stitution of a hydroxyl group for a hydrogen atom in the acetyl radical of the aglycone moiety of daunomycin [2]. Adriamycin was reported to possess a higher therapeutic index than daunomycin in serval experimental tumor systems [3, 4]. This paper deals with cross-resistance studies using various re
33#
發(fā)表于 2025-3-27 07:33:27 | 只看該作者
Cross-resistance between Adriamycin, Daunomycin and Vincristine in Ehrlich Ascites Tumor been done using experimental tumors as model systems. In the present investigation, the development of resistance to several drugs, including daunomycin and adriamycin, was studied in Ehrlich ascites tumor . in mice.
34#
發(fā)表于 2025-3-27 13:13:57 | 只看該作者
35#
發(fā)表于 2025-3-27 14:07:06 | 只看該作者
36#
發(fā)表于 2025-3-27 20:24:05 | 只看該作者
Structure and Physicochemical Properties of Adriamycin (Doxorubicin)he tetracyclic quinoid aglycone adriamycinone (14-hydroxydaunomycinone) linked to the amino- sugar daunosamine. The chemical name for adriamycin is therefore the following: (7S : 9S)-9-hydroxyacetyl-4-methoxy-7,8,9,10-tetrahydro-6,7,9, ll-tetrahydroxy-7-0- (2′3′6′-trideoxy-3′-amino-α-L-lyxohexopyranosyl)-5,12-naphthacenedione.
37#
發(fā)表于 2025-3-28 00:10:18 | 只看該作者
38#
發(fā)表于 2025-3-28 03:30:15 | 只看該作者
39#
發(fā)表于 2025-3-28 06:57:48 | 只看該作者
40#
發(fā)表于 2025-3-28 13:16:52 | 只看該作者
Short Summary of the Informal Meeting Preceeding the Adriamycin SymposiumDespite the large number of growth-inhibiting compounds isolated and proved to be active against neoplastic cells in . cultures or in animal tumors, the final goal of a highly efficient and safe therapy of human tumor is not yet achieved.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-28 15:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
九台市| 钟山县| 平武县| 崇明县| 林口县| 衡阳县| 桓台县| 辽源市| 洱源县| 延津县| 佳木斯市| 西乌珠穆沁旗| 洛宁县| 中阳县| 射洪县| 阿城市| 云霄县| 灵川县| 健康| 荥阳市| 麟游县| 丰城市| 西青区| 镇坪县| 浮梁县| 曲麻莱县| 比如县| 昌乐县| 天等县| 乌鲁木齐县| 建水县| 岳普湖县| 弋阳县| 花垣县| 双桥区| 密云县| 太保市| 朔州市| 瑞安市| 溧阳市| 涞水县|